The Power of the Pulse: Electroporation's Dominance in CAR-T Cell Therapy and the Transfection Technology Market
The field of oncology is undergoing a historic paradigm shift, moving away from broad-spectrum chemotherapies and towards hyper-targeted, personalized immunotherapies. At the vanguard of this movement is Chimeric Antigen Receptor T-cell (CAR-T) therapy, a process that engineers a patient's own immune system to hunt and destroy cancer. However, creating these "living drugs" requires a highly...
0 Commenti
0 condivisioni
44 Views
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Russian
Romaian
Portuguese (Brazil)
Tiếng Việt